In Early Research, Heart Drugs Show Promise in Fighting Muscular Dystrophy
WEDNESDAY, Jan. 3, 2024 (HealthDay News) — A regularly prescribed class of heart medications might be capable of treating one of the most common forms of muscular dystrophy, a new study in mice suggests. Myotonic dystrophy type 1 (DM1) is caused by abnormal RNA that affects the function of calciumContinue Reading